Is HealthStream (HSTM) overvalued or fairly valued?

MarketChacha shows HealthStream's valuation in context — a trailing P/E of about 37.7, a forward P/E of about 31.4, a price-to-book of about 2.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does HealthStream's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (3.45×) from reported figures — education, not a rating.

What is HealthStream's revenue?

HealthStream reported revenue of $304.1M for FY2025, with net profit of $18.3M, per official filings.

What is the share price of HealthStream (HSTM)?

HealthStream last traded at $27.16 (-2.4% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

HealthStream

HSTM · NYSE · Healthcare · United States

$27.16-2.4%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:31 PM

Snapshot

TickerHSTM

ExchangeNYSE

SectorHealthcare

IndustryHealth Information Services

CountryUnited States

Employees1,139

HeadquartersNashville, United States

Market cap$793.5M

P/E (TTM)37.7

P/B2.3

Volume138.93K

Websitewww.healthstream.com

Filings tracked4

About HealthStream

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company offers hStream, a technology platform; CredentialStream, provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure and other credentials, privileging, appointments by credentialing committees, enrollment, network, management, onboarding, and performance evaluations of providers; ShiftWizard; and Competency Suite, AI/ML-driven clinical competency development system. It also provides applications for performance appraisal, competency management, disclosure management, clinical competency, assessment, development, simulation-based education, clinical rotation and onboarding management, quality management, and industry training. The company's solutions help healthcare organizations in meeting their ongoing learning, clinical development, credentialing, and scheduling needs. It serves the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies, and nursing schools and students. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.

Profile as reported by Yahoo Finance.

Who owns it

Insiders20.5%
Institutions74.7%
Public & other4.9%

293 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.13.18%
Dimensional Fund Advisors LP4.98%
Copeland Capital Management, LLC4.37%
Vanguard Capital Management LLC3.59%
State Street Corporation3.41%
Vanguard Portfolio Management LLC3.16%
Two Sigma Investments, LP2.89%
Geode Capital Management, LLC2.45%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

Latest ROE of 5.2% is on the low side — the business earns a modest return on shareholder capital.

Cash conversion3.45×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend5.5% → 6.0%

Margin has held broadly steady over the period — stable profitability.

Return on equity5.2%

Latest ROE of 5.2% is on the low side — the business earns a modest return on shareholder capital.

Growth qualityrev 4% · PAT 10%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $81.9M · EPS 0.19

Est. earnings growth -5.0%

Next fiscal year

Rev $343.3M · EPS 0.86

Est. earnings growth +10.2%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$19.5052-wk range$30.00

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$793.5M

Day change

-2.4%

P/E (TTM)

37.7

Fwd P/E

31.4

P/B

2.3

Div yield

0.47%

Beta

0.45

Revenue (FY2025)

$304.1M

Net margin

6.0%

ROE

5.2%

Revenue CAGR (2y)

+4.4%

Profit CAGR (2y)

+9.8%

EPS (FY2025)

0.61

Net profit (FY2025)

$18.3M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about HSTM

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$304.1M	$18.3M	0.61	6.0%	5.2%
FY2024	$291.6M	$20.0M	0.66	6.9%	5.6%
FY2023	$279.1M	$15.2M	0.50	5.5%	4.5%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$81.2M	$5.9M	0.20	7.3%
2025Q3	$76.5M	$6.1M	0.20	8.0%
2025Q2	$74.4M	$5.4M	0.18	7.2%
2025Q1	$73.5M	$4.3M	0.14	5.9%
2024Q3	$73.1M	$5.7M	0.19	7.8%
2024Q2	$71.6M	$4.2M	0.14	5.8%
2024Q1	$72.8M	$5.2M	0.17	7.2%
2023Q3	$70.3M	$3.9M	0.13	5.5%
2023Q2	$69.2M	$4.1M	0.13	6.0%
2023Q1	$68.9M	$2.6M	0.09	3.8%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Shareholder vote results, Exhibits
SEC5/29/2026material
8-K — Executive/director change
SEC5/8/2026material
10-Q — FORM 10-Q
SEC5/6/2026
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC5/4/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.